Effect of Early Treatment of Newborns by Peroral Colonization Using Non-pathogenic E. coli on the Development of Their Immuno- allergic System

Author(s): Jiri Liska, Konrad Siala, Vaclav Holecek, Stepanka Sobotova, Monika Kepkova, RNDr. Ing. Frantisek Sefrna.

Journal Name: Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)

Volume 1 , Issue 2 , 2014

Become EABM
Become Reviewer

Abstract:

In our previous work, we presented the results of a 12-year study (1998-2010) from which we derived several important conclusions. This was a large cohort, in which were examined 3619 samples of umbilical cord blood. We reached several conclusions from which it was clear that allergy was significantly associated with a positive family history (statistical significance at 1 ‰). The first symptoms of allergic disease occurred in the first years of life. We also observed significant seasonal differences. High levels of umbilical IgE and a positive family history were found to be grounds for preventive intervention by influencing the microbial flora of the gastrointestinal tract (GIT). We used Colinfant Newborn peroral probiotic vaccine - a lyophilized non-pathogenic strain of E. coli. The results in 2005-2008 and 2008-2009 confirmed that in treated patients with primary elevated levels of immunoglobulin E (IgE) in umbilical cord blood, IgE values at one year of age fully normalized in 90 %. The medical history of these children indicated minimal sickness rates. We further investigated IgG values at one year of age and compared this with a control group. After treatment these levels were also normalized. From 2009-2012, we investigated the effect of treatment on the values of immunoglobulins IgE, IgG, but also IgA, and statistically processed the data at 1 year of age and 3 years of age. Statistically, a correlation was observed between IgG and IgA in the 1st year of life and at 3rd years of age with a significance level of 1 ‰. The results show that treatment with Colinfant has a positive effect in the sense that the resulting IgE did not statistically significantly differ from referent values of healthy children. These values changed in time in treated patients between the 1st and 3rd year at a significance level of 1 ‰. IgG and IgA in treated patients were, in median, entirely within the values of normality. In the period after 1 year, we found significant correlations of umbilical IgE with serum IgE, IgG, IgA and correlation of serum IgG with IgA. Very favourable effects of therapy on sickness rate of children compared to control group in a predefined file of the same age period is shown graphically.

Keywords: Allergy, immunology, newborn, probiotics, therapy-newborn.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 1
ISSUE: 2
Year: 2014
Page: [111 - 121]
Pages: 11
DOI: 10.2174/2212703802666150127001859
Price: $58

Article Metrics

PDF: 6